Ember LifeSciences
PrivateLast Round
Series A
May 27, 2026
Total Funding Raised
$54M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Ember LifeSciences operates in Healthcare & Life Sciences and is based in Westlake Village, California. Its latest recorded funding round was a Series A round in May 2026.
Ember LifeSciences is a cold chain technology company that provides self-refrigerated, cloud-based shipping solutions for the transport of temperature-sensitive pharmaceuticals and vaccines.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Logistics Software, Supply Chain Tracking, Circular Economy
Business Model
B2B
Customer Profile
Hardware + Subscription, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ember LifeSciences Comparables
Compare Ember LifeSciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Artyc | 89% | |
| SkyCell | 79% | |
| Cold Chain Technologies | 76% |
For institutional investors. Book with your work email.
Ember LifeSciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 27, 2026 | ||||
| Series A | Dec 16, 2025 | ||||
| Early Stage VC | Jun 16, 2025 | ||||
| Early Funding | Feb 14, 2023 |
For institutional investors. Book with your work email.
Ember LifeSciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TDF Ventures | Series A |
| Carrier Ventures | Series A, Early Funding |
| Amgen Ventures | Series A |
| Sea Court Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 28, 2026
Open roles increased to 9, representing 33% of headcount.
- Aug 31, 2026
Open roles increased to 8, 3.1x the trailing average.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresAug 11, 2026
Ember LifeSciences, Inc. appoints James Braithwaite as Chief Product Officer in California on Aug 11th '26; he leads product strategy and development across its next-generation cold chain solutions and patient-centric devices.
For institutional investors. Book with your work email.
Ember LifeSciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ember LifeSciences's valuation, stock price, and market status.
Is Ember LifeSciences a public or private company?
Ember LifeSciences is a private company.
What is the current stock price of Ember LifeSciences?
Ember LifeSciences is a private company, so its shares have no public market price. Caplight tracks Ember LifeSciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ember LifeSciences worth (valuation)?
Valuation information for Ember LifeSciences is not publicly available.
Can I buy Ember LifeSciences stock?
Ember LifeSciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ember LifeSciences's last funding round?
Ember LifeSciences's most recent funding round was Series A on May 27, 2026.
Who are the main investors in Ember LifeSciences?
Key investors in Ember LifeSciences include TDF Ventures, Carrier Ventures, Amgen Ventures, Sea Court Capital.
Will Ember LifeSciences IPO soon?
No public IPO plans have been announced for Ember LifeSciences.
How can I track Ember LifeSciences secondary market activity?
Caplight tracks bids, offers, and trades in Ember LifeSciences's shares on secondary markets.